<unk>  or<unk>  therapies of multiple endocrine neoplasia type 1 include TRK inhibitors (tropomyosin receptor kinase inhibitors), mTOR inhibitors, thienopyrimidine analogs and molecular phenotyping.
Multiple endocrine neoplasia type 1 future or investigational therapies
Multiple endocrine neoplasia type 2 future or investigational therapies
Multiple endocrine neoplasia type 2 secondary prevention
Multiple endocrine neoplasia type 1 secondary prevention
Multiple endocrine neoplasia type 2 medical therapy
Multiple endocrine neoplasia type 1 surgery
Multiple endocrine neoplasia type 2 surgery
Multiple endocrine neoplasia type 1 medical therapy